⌘K

Login Start Free

Home/Filings/4/0001193125-25-327030

4//SEC Filing

Jones Jeffrey Alan 4

Accession 0001193125-25-327030

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:00 PM ET

Size

5.0 KB

Accession

0001193125-25-327030

Insider Transaction Report

Form 4

Period: 2025-12-18

Cullinan Therapeutics, Inc.CGEM

Jones Jeffrey Alan

Chief Medical Officer

Transactions

Sale
Common Stock
2025-12-18$9.67/sh−4,632$44,791→ 169,532 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001914647

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 5:00 PM ET
Size: 5.0 KB

View on SEC.gov